Search research articles
Contact Us
Filters
Showing results (21-30 of 133) with videos related to
Page
of 14
Sort By:
Oncotargets and Therapy
|
July 27, 2018
<i>TERT</i> copy gain predicts the outcome of high-dose interferon α-2b therapy in acral melanoma
Sifan Yu, Tianxiao Xu, Jie Dai, et al.
Clinical Nuclear Medicine
|
January 29, 2021
Positron Emission Tomography Imaging of Programmed Death 1 Expression in Cancer Patients Using 124I-Labeled Toripalimab: A Pilot Clinical Translation Study
Shujing Wang, Hua Zhu, Jin Ding, et al.
Oncotarget
|
February 20, 2016
Efficacy and safety of sorafenib versus sunitinib as first-line treatment in patients with metastatic renal cell carcinoma: largest single-center retrospective analysis
Xinan Sheng, Zhihong Chi, Chuanliang Cui, et al.
Thoracic Cancer
|
March 14, 2019
Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features, management, and survival of 76 patients
Xuan Wang, Yan Kong, Zhihong Chi, et al.
Bladder (San Francisco, Calif.)
|
December 29, 2023
Advances in HER2-Targeted Treatment for Advanced/Metastatic Urothelial Carcinoma
Mengnan Qu, Li Zhou, Xieqiao Yan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Major response to everolimus in melanoma with acquired imatinib resistance
Lu Si, Xiaowei Xu, Yan Kong, et al.
International Journal of Cancer
|
February 13, 2007
Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma
Jun Guo, Jun Zhu, Xinan Sheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2015
Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors
Yan Kong, Lu Si, Yiqian Li, et al.
Annals of Surgical Oncology
|
December 23, 2017
Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China
Siming Li, Xinan Sheng, Lu Si, et al.
Zhonghua Yi Xue Za Zhi
|
December 30, 2015
[Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma]
Bixia Tang, Zhihong Chi, Xinan Sheng, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 133) with videos related to
Sort By:
Page
of 14
Oncotargets and Therapy
|
July 27, 2018
<i>TERT</i> copy gain predicts the outcome of high-dose interferon α-2b therapy in acral melanoma
Sifan Yu, Tianxiao Xu, Jie Dai, et al.
Clinical Nuclear Medicine
|
January 29, 2021
Positron Emission Tomography Imaging of Programmed Death 1 Expression in Cancer Patients Using 124I-Labeled Toripalimab: A Pilot Clinical Translation Study
Shujing Wang, Hua Zhu, Jin Ding, et al.
Oncotarget
|
February 20, 2016
Efficacy and safety of sorafenib versus sunitinib as first-line treatment in patients with metastatic renal cell carcinoma: largest single-center retrospective analysis
Xinan Sheng, Zhihong Chi, Chuanliang Cui, et al.
Thoracic Cancer
|
March 14, 2019
Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features, management, and survival of 76 patients
Xuan Wang, Yan Kong, Zhihong Chi, et al.
Bladder (San Francisco, Calif.)
|
December 29, 2023
Advances in HER2-Targeted Treatment for Advanced/Metastatic Urothelial Carcinoma
Mengnan Qu, Li Zhou, Xieqiao Yan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Major response to everolimus in melanoma with acquired imatinib resistance
Lu Si, Xiaowei Xu, Yan Kong, et al.
International Journal of Cancer
|
February 13, 2007
Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma
Jun Guo, Jun Zhu, Xinan Sheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2015
Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors
Yan Kong, Lu Si, Yiqian Li, et al.
Annals of Surgical Oncology
|
December 23, 2017
Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China
Siming Li, Xinan Sheng, Lu Si, et al.
Zhonghua Yi Xue Za Zhi
|
December 30, 2015
[Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma]
Bixia Tang, Zhihong Chi, Xinan Sheng, et al.
Page
of 14